Achieve Life Sciences Stock (NASDAQ: ACHV) stock price, news, charts, stock research, profile.
Open | $4.53 |
Close | $4.60 |
Volume / Avg. | 233.21K / 221.10K |
Day Range | $4.50 - $4.63 |
52 Wk Range | 3.03 - 5.98 |
Market Cap | $157.97M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 11.5% |
Days to Cover | 33.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Galectin Therapeutics (NASDAQ:GALT).
Achieve Life Sciences has a consensus price target of $15.00.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $4.6 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.